Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E W Hancock

Showing results (31-40 of 501) with videos related to

Pageof 51
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatmentRobert E. W. Hancock, David P. Speert
Current Pharmaceutical Design|April 12, 2002
Cationic peptides: distribution and mechanisms of resistanceDeirdre A Devine, Robert E W Hancock
Current Opinion in Immunology|December 13, 2005
Cationic host defense (antimicrobial) peptidesKelly L Brown, Robert E W Hancock
Antimicrobial Agents and Chemotherapy|July 29, 2005
Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosaMichelle D Brazas, Robert E W Hancock
Biochimica Et Biophysica Acta|April 18, 2006
Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptidesSuzana K Straus, Robert E W Hancock
FEMS Microbiology Reviews|February 27, 2009
Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosaW James Gooderham, Robert E W Hancock
Pathogens and Disease|April 27, 2013
Pseudomonas aeruginosa: new insights into pathogenesis and host defensesShaan L Gellatly, Robert E W Hancock
Critical Reviews in Immunology|November 26, 2008
Neutrophil-derived defensins as modulators of innate immune functionLinda M Rehaume, Robert E W Hancock
Drug Discovery Today|October 11, 2005
Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistanceMichelle D Brazas, Robert E W Hancock
Biopolymers|April 5, 2013
Peptide design for antimicrobial and immunomodulatory applicationsEvan F Haney, Robert E W Hancock
Pageof 51

Showing results (31-40 of 501) with videos related to

Sort By:
Pageof 51
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatmentRobert E. W. Hancock, David P. Speert
Current Pharmaceutical Design|April 12, 2002
Cationic peptides: distribution and mechanisms of resistanceDeirdre A Devine, Robert E W Hancock
Current Opinion in Immunology|December 13, 2005
Cationic host defense (antimicrobial) peptidesKelly L Brown, Robert E W Hancock
Antimicrobial Agents and Chemotherapy|July 29, 2005
Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosaMichelle D Brazas, Robert E W Hancock
Biochimica Et Biophysica Acta|April 18, 2006
Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptidesSuzana K Straus, Robert E W Hancock
FEMS Microbiology Reviews|February 27, 2009
Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosaW James Gooderham, Robert E W Hancock
Pathogens and Disease|April 27, 2013
Pseudomonas aeruginosa: new insights into pathogenesis and host defensesShaan L Gellatly, Robert E W Hancock
Critical Reviews in Immunology|November 26, 2008
Neutrophil-derived defensins as modulators of innate immune functionLinda M Rehaume, Robert E W Hancock
Drug Discovery Today|October 11, 2005
Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistanceMichelle D Brazas, Robert E W Hancock
Biopolymers|April 5, 2013
Peptide design for antimicrobial and immunomodulatory applicationsEvan F Haney, Robert E W Hancock
Pageof 51